INTRODUCTION: The function, peripheral blood expression, and physiologic importance of IL-17 is not well established. Detection of IL-17 in sera and plasma samples from patients with pre-eclampsia has been reported with inconsistent results. To establish the l levels of the IL-17 at peripheral level, we studied prospectively a cohort of 13 healthy pregnant women. OBJECTIVE: To evaluate the changes in serum levels of IL-17 in healthy pregnant women in a prospective cohort. MATERIAL AND METHODS: Thirteen healthy pregnant women were prospectively followed to evaluate serum levels of IL-17. Each patient was evaluated at each trimester. IL-17 levels were measured by ELISA. The statistical analysis was done using repeated measures anova and Bonferroni's multiple comparison test. RESULTS: IL-17 levels were significantly increased from first trimester with a mean of 14.61 up to 31.78 pg/mL at third trimester (P < 0.05), but when detectable, they were almost identical range in all trimesters. CONCLUSIONS: We propose that IL-17 levels in healthy women are present with very similar range levels during the whole pregnancy but the average is increased during the third trimester maybe as a part of the complex network of cytokines as a result of implantation, fetal development, and labor process itself.
INTRODUCTION: The function, peripheral blood expression, and physiologic importance of IL-17 is not well established. Detection of IL-17 in sera and plasma samples from patients with pre-eclampsia has been reported with inconsistent results. To establish the l levels of the IL-17 at peripheral level, we studied prospectively a cohort of 13 healthy pregnant women. OBJECTIVE: To evaluate the changes in serum levels of IL-17 in healthy pregnant women in a prospective cohort. MATERIAL AND METHODS: Thirteen healthy pregnant women were prospectively followed to evaluate serum levels of IL-17. Each patient was evaluated at each trimester. IL-17 levels were measured by ELISA. The statistical analysis was done using repeated measures anova and Bonferroni's multiple comparison test. RESULTS:IL-17 levels were significantly increased from first trimester with a mean of 14.61 up to 31.78 pg/mL at third trimester (P < 0.05), but when detectable, they were almost identical range in all trimesters. CONCLUSIONS: We propose that IL-17 levels in healthy women are present with very similar range levels during the whole pregnancy but the average is increased during the third trimester maybe as a part of the complex network of cytokines as a result of implantation, fetal development, and labor process itself.
Authors: Valéria de Lima Kaminski; Joel Henrique Ellwanger; Maria Cristina Cotta Matte; Ricardo Francalacci Savaris; Priscila Vianna; José Artur Bogo Chies Journal: Mol Biol Rep Date: 2018-07-28 Impact factor: 2.316
Authors: Olawunmi R Rabiu; Hannah Dada-Adegbola; Catherine O Falade; Olatunbosun G Arinola; Alexander B Odaibo; Olusegun G Ademowo Journal: Parasitol Res Date: 2022-05-06 Impact factor: 2.289
Authors: Sonal Mahilkar; Sachin K Malagi; Abhishek Soni; Dennis V Abraham; Lynn Johnson; Kirti S Pattanshetti Journal: J Obstet Gynaecol India Date: 2021-02-25
Authors: Gloria B Choi; Yeong S Yim; Helen Wong; Sangdoo Kim; Hyunju Kim; Sangwon V Kim; Charles A Hoeffer; Dan R Littman; Jun R Huh Journal: Science Date: 2016-01-28 Impact factor: 47.728
Authors: Erin B Taylor; Eric M George; Michael J Ryan; Michael R Garrett; Jennifer M Sasser Journal: Am J Physiol Regul Integr Comp Physiol Date: 2021-06-09 Impact factor: 3.210
Authors: Elizabeth Ann L Enninga; Wendy K Nevala; Douglas J Creedon; Svetomir N Markovic; Shernan G Holtan Journal: Am J Reprod Immunol Date: 2014-08-04 Impact factor: 3.886